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The CD4 antigen is a plasma membrane glycoprotein of ^-55 kD that is
expressed on most thymocytes and on Th cells in all mammalian species exam-
ined, including human, rat, mouse, sheep, and pig (1) . The antigen is also present
on rat macrophages (MO) and human monocytes in a similar molecular form (2,
3) . Studies with mAbs (4)havedemonstrated that CD4 on Th cells is an important
accessory molecule involved in recognition of antigen plus MHC class II mole-
cules during immune responses . In humans, a more recently defined property
of the CD4 antigen is to act as the receptor for the AIDS virus (human
immunodeficiency virus or HIV) (5) . Although nothing is known concerning the
the regulation and functional significance ofCD4 expression on MO, its presence
is likely to be at least one reason why these cells become infected by HIV (6, 7) .
Here we demonstrate that, unlike human and rat M0, mouse Mo do not express
the CD4 (L3T4) antigen . This species disparity indicates, firstly, that CD4 may
notbe essential for Mo function, and secondly, that MO regulate CD4 expression
differently from Th cells .
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Materials and Methods
BriefDefinitive Report
Animals.
￿
Specific pathogen-free C57BL/6 mice and AO rats were bred at the Sir
William Dunn School of Pathology and both sexes were used between 6 and 12 wk of age .
Antibodies.
￿
The following rat mAbs to mouse CD4 (L3T4) were obtained as shown
and used as tissue culture supernatants at saturation : H129.19 (IgG2a) (8), RL 172.4
(IgM) (9), and GK1 .5 (IgG2b) (10), provided by Dr . H . R . MacDonald, Ludwig Institute
for Cancer Research, Lausanne, Switzerland; and YTS 191 .1 (IgG2b) andYTA.3 (IgG2b)
(11), provided by Dr . S . P . Cobbold, Department of Pathology, Cambridge University,
Cambridge, United Kingdom . The noncompeting mouse anti-rat CD4 (W3/25) mAbs,
W3/25 (IgGI) and MRC OX-35 (IgG2a) (2), were from the MRC Cellular Immunology
Research Unit, University of Oxford, Oxford, United Kingdom . Other mAbs used were
MRC OX-21 (IgGI), a mouse mAb to human C3b inactivator (2), and F4/80 (IgG2b), a
rat mAb specific for mature mouse Mo (12) .
Labeling of Cells with Antibodies .
￿
Mouse and rat resident peritoneal MO were purified
by adherence for 1 h to bacteriologic petri dishes followed by extensive washing . The
adherent cells (>90% Mo by morphology) were detached by a 15-min incubation in
calcium- and magnesium-free PBS at 37°C followed by gentle pipetting . Thymocytes
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were obtained by teasing thymuses in PBS containing 0.1 % BSAand 10 mM sodium azide
(PBA). Thymocytes and Mo were labeled at 4°C with first antibody diluted in PBA
followed either by FITC-conjugated OX12 F(ab')2 (mouse anti-rat K chain, used with
mouse cells) or FITC-rabbit anti-mouse F(ab')2 (2) (with rat cells). Fluorescence histo-
grams were obtained on a Becton Dickinson & Co. (Mountain View, CA) FACS II with
104 cells analyzed for each profile and with cell number shown on a linear scale.
Northern Blot Hybridization.
￿
Mouse and rat thioglycollate-elicited peritoneal M4) (12)
were purified (>95%) by adherence for 1 h to tissue culture-treated petri dishes followed
by extensive washing to remove lymphocytes. Human monocytes were purified similarly
and cultured for 12 d in RPMI 1640 containing 10% autologous serum. RNAs were
isolated as described (13) and where indicated, poly(A)+ RNA was selected by oligo(dT)
cellulose chromatography. Rat and mouseRNA samples were resolved on a 1.2% agarose-
formaldehyde gel, transferred to Gene Screen (New England Nuclear, Boston, MA) and
hybridized with both nick-translated rat CD4 cDNA (1) and human lysozyme cDNA (L.
P. Chung, unpublished). The filter was washed with 2x SSC at 65°C and exposed to
autoradiographic film for 5 d. The human sample was resolved on a 1.0% agarose-
formaldehyde gel, transferred to Gene Screen, and hybridized with human lysozyme
cDNA or human CD4 cDNA (14), kindly provided by Dr. P. J. Maddon, Columbia
University, New York. The filter was washed with 3x SSC at 65°C and exposed for 1
(lysozyme) or 7 d (CD4).
Immunoperoxidase Analysis.
￿
10-jM tissue cryostat sections were fixedwith acetoneand
stained using an avidin-biotin immunoperoxidase detection system (Vectastain; Seralab,
Crawley Down, United Kingdom). Preparations were counterstained with Mayer's hem-
alum and photographed using a dark blue filter.
Results and Discussion
FACS Analysis. To investigate the expression of CD4 (L3T4) on mouse
peritoneal Mo we first tested by FACS analysis the binding of four competing
rat anti-mouse CD4 (L3T4) mAbs of different isotypes. Both freshly harvested
and adherence-purified resident or inflammatory peritoneal MO were studied,
but in six independent experiments we were unable to demonstrate labeling of
Mo from either C57BL/6 or BALB/c mice. Mouse thymocytes were clearly
labeled by each antibody in each experiment . In a representative experiment,
shown in Fig. 1, there was no binding of H129.19 (8) to purified resident
peritoneal Mo abovethe background levels using FITC-OX12 F(ab')2 alone(Fig.
la), while mouse thymocytes showed clear labeling (Fig. 1c). The failure of
mouse M¢ to label with antibodies to CD4 (L3T4) was not due to poor viability
since the majority were strongly labeled with the Mo-specific mAb F4/80 (12)
(Fig. 1 a), and >85% excluded trypan blue after each experiment. In addition,
rat (AO) resident peritoneal Mo purified simultaneously by the same method
were strongly labeled with either OX35 or W3/25, two noncompeting mouse
mAbs to rat CD4 (2) (Fig. 1 b and d).
Northern Blot Hybridization.
￿
Direct evidence that mouse peritoneal Mo do
not express the CD4 (L3T4) antigen was provided by Northern blot analysis
using a rat CD4 cDNA probe (1) (Fig. 2). As an internal control for the presence
of Mo RNA, we also screened the filter with a cDNA probe to human lysozyme
mRNA. It can be seen in Fig. 2, lane 4, that with mouse thymocytes the expected
3.7-kb CD4 (L3T4) mRNA was readily detected by crosshybridization of the rat
probe with <20 ,ug total mouse thymocyte RNA. In contrast, no CD4 (L3T4)
mRNA could be detected in mouse MQ> (Fig. 2, lanes 5-8), even with up to 10
ug purified mRNA [poly(A)+] and with prolonged exposure (3 wk). In addition,
CD4 (L3T4) mRNA was not induced by 3-d in vitro cultivation of mousew
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FIGURE 1 .
￿
FACS analysis to investigate CD4 expression on mouse MO and thymocytes in
comparison with rat Mo and thymocytes . (a) Purified mouse resident peritoneal MO showing
undetectable labeling with H129.19 (anti-mouse CD4 (L3T4)) compared with background
labeling with fluoresceinated second antibody alone (FITC) . Labeling with F4/80 shown as a
positive control. (b) Purified rat resident peritoneal M¢ labeled with OX35 (anti-rat CD4
(W3/25)) compared with OX21 used as negative control . (c) Mouse thymocytes labeled with
H129.19 compared with F4/80 used as a negative control. (d) Rat thymocytes labeled with
OX35 compared with OX21 . Ratanti-mouseCD4(L3T4) mAbs tested in addition to H129.19
were GK1 .5, YTS 191.1, and RL 172.4 . The noncompeting mAb to mouse CD4 (L3T4),
YTA.3, nonspecifically labeled -50% ofM¢ via binding to Fc receptors (data not shown).
FIGURE 2 . Northern blot analysis
of RNAs isolated from thymocytes
and purified MO, probed with either
human(lane 1) or rat (lanes2-8)CD4
cDNA and human lysozyme cDNA .
(1) 20 ug total RNA from purified
human monocytes cultured for 12 d
and probed with CD4 mRNA (top
panel) or lysozyme mRNA (bottom
panel) ; (2) 20 I;g total RNA from rat
exudate peritoneal MO ; (3) 10 wg to-
tal RNA from rat thymocytes; (4) 18
jug total RNA from mouse thymo-
cytes; (5 and 6) 10 jug and 2 tag
poly(A)* RNA from mouse exudate
peritoneal MO respectively ; (7) 20 Wg
total RNA from mouseexudate per-
itoneal MO ; (8) 20 jag total RNAfrom
mouse exudate MO after culture for
3 d .616
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FIGURE 3 .
￿
Immunocytochemical analysis of mouse spleen and liver demonstrating absence
ofCD4 (L3T4) on tissue MO . (a) Staining ofT cells but not red pulp (RP)MO forCD4 (L3T4)
in spleen ; (b) lack of staining of Kupffer cells forCD4 (L3T4) in liver ; (c) staining of red pulp
(RP) M¢ with F4/80 in serial section of spleen ; (d) staining of Kupffer cells with F4/80 in
serial section of liver. The asterisks in a and c overlie a splenic arteriole that is common to
both sections. Scale bars indicate 20kM .
peritoneal MO (Fig . 2, lane 8) and could not be detected in total RNA samples
from the murine MO-like cell lineJ774.2 (data not shown) . There was also no
evidence of hybridization to a 2.7-kb CD4mRNA species recently demonstrated
in poly(A)' RNA isolated from human and mouse brain (5, 15) . Since human
(but not mouse) brain also expresses the normal sizedCD4mRNA (5), our results
lend support to the suggestion that the 2.7-kb CD4 mRNA is derived from cells
other than microglia (brain MO) (5) . The presence of intact mouse MO mRNA
in each lane was confirmed by the strong signals obtained by hybridization of
the lysozyme probe to 1.5-kb mouse lysozyme mRNA . The lower molecular
weight bands (<1 .5 kb) observed with some mouse Mo samples (Fig . 2, lanes 5
and 7) were due to hybridization to the lysozyme probe . In contrast to the
mouse, human andratMO clearly expressed CD4mRNA in addition to lysozyme
mRNA (Fig . 2, lanes 1 and 2) .
Immunocytochemistry.
￿
To determine whether other mouse tissue MO popula-
tions failed to express theCD4 (L3T4) antigen we investigated its expression on
spleen and liver Mo by using a sensitive avidin-biotin immunoperoxidase detec-
tion system and mixtures of the noncompeting mAbs, YTS 191 .1 and YTA.3
(11) (Fig . 3) . In mouse spleen there was clear labeling ofT cells, but M¢ in the
marginal zone or red pulp were not stained (Fig . 3 a) . With mouse liver there
was no labeling of any cell population for CD4 (L3T4) antigen (Fig . 3b). To
control for the presence of structurally intact M¢ in both tissues, serial sections
were stained with mAb F4/80 . This revealed intense labeling of M¢ in the redCROCKER ET AL.
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pulp of the spleen (Fig. 3c), while in liver, Kupffer cells were clearly evident
(Fig. 3d). These results are, again, in stark contrast to the rat in which labeling
of splenic MO and Kupffer cells could easily be detected by conventional two-
layer immunoperoxidase techniques (not shown).
In view ofthe 2.7-kb CD4 (L3T4) mRNA reported in mouse brain (5, 15), we
also examined sections ofthis tissue. However, in contrast to the human and rat
(reference 16, and Perry, V. H., personal communication), we have so far not
observed specific staining for CD4 (L3T4) in mouse brain, either on microglia,
choroid plexus MO, or other cell populations. Finally, CD4 (L3T4) expression
was not detectable on activated peritoneal MO obtained from BCG-infected mice
(not shown).
These results demonstrate that expression of CD4 on Th cells and MO can be
uncoupled. This implies that each cell type regulates the expression of CD4 by
differing mechanisms. If this is the case, mouse MO may be suppressed or lack
one or more ofthe regulatory components required. As yet, the significance of
CD4 on MO is unknown but if the molecule performs essential functions in
species such as the rat and human, then the mouse must have evolved different
mechanisms to carry these out. Alternatively, CD4 may be nonessential or even
without a function on Mo. In humans, the only known `function' of CD4 on
monocytes is to act as a receptor for HIV, resulting in a low-grade but persistent
infection of these cells in vitro (6, 7). Clearly, the species heterogeneity in MO
expression of the CD4 antigen should be taken into account when assessing the
use ofanimal models ofHIV infection, since it is possible that therelative number
of CD4 molecules on tissue Mo is an important determinant of their innate
susceptibility to infection by HIV in vivo. In rats, MO display similar levels of
CD4 to Th cells (Jefferies, W. A., unpublished observations), but whether an
analogous situation exists in humans is unknown. An understanding of the
mechanisms by which Mo regulate expression of CD4 is therefore of direct
relevance not only to the functional significance of the molecule on these cells,
but also with respect to its role as a human Mo receptor for HIV.
Summary
The CD4 antigen is expressed on T cells ofall mammalian species examined
and appears to play an important role in the response of T cells to antigen. In
humans, the molecule acts as a receptor for the AIDS virus. Previous studies (2,
3) have demonstrated that Mo in the rat and human also express the CD4
antigen, which is indistinguishable from that on T cells. In this paper we
demonstrate by FACS analysis, Northern blot hybridization, and immunoper-
oxidase labeling that, in striking contrast to the rat and human, mouse MO do
not express the CD4 (L3T4) antigen. This species heterogeneity indicates that
T cells and M¢ regulate CD4 antigen expression independently and that CD4
may not be essential for Mo function.
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